AdvisorShares Investments LLC purchased a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the second quarter, according to its most recent filing with the SEC. The firm purchased 10,930 shares of the company’s stock, valued at approximately $420,000.
A number of other large investors have also recently bought and sold shares of BBWI. Envestnet Portfolio Solutions Inc. grew its stake in shares of Bath & Body Works by 5.2% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 5,571 shares of the company’s stock valued at $279,000 after buying an additional 277 shares during the period. Empirical Finance LLC grew its stake in shares of Bath & Body Works by 3.6% in the 1st quarter. Empirical Finance LLC now owns 8,097 shares of the company’s stock valued at $405,000 after buying an additional 278 shares during the period. Comerica Bank grew its stake in shares of Bath & Body Works by 0.9% in the 4th quarter. Comerica Bank now owns 33,091 shares of the company’s stock valued at $1,428,000 after buying an additional 280 shares during the period. CWM LLC grew its stake in shares of Bath & Body Works by 6.6% in the 2nd quarter. CWM LLC now owns 5,072 shares of the company’s stock valued at $198,000 after buying an additional 314 shares during the period. Finally, Northwest Bank & Trust Co grew its stake in shares of Bath & Body Works by 2.5% in the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after buying an additional 315 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.
Bath & Body Works Stock Up 1.0 %
Bath & Body Works stock opened at $26.99 on Thursday. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99. The company’s 50 day moving average price is $33.76 and its two-hundred day moving average price is $41.62. The stock has a market cap of $6.03 billion, a P/E ratio of 6.96, a P/E/G ratio of 0.97 and a beta of 1.77.
Bath & Body Works Dividend Announcement
Analyst Ratings Changes
Several brokerages have recently commented on BBWI. Robert W. Baird reduced their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Piper Sandler reduced their target price on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a research note on Thursday, July 11th. JPMorgan Chase & Co. reduced their target price on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating for the company in a research note on Thursday, August 29th. Morgan Stanley cut their price target on Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating for the company in a research note on Thursday, September 5th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on Bath & Body Works from $57.00 to $54.00 and set a “buy” rating for the company in a research note on Monday, August 26th. Eight research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $43.00.
Check Out Our Latest Stock Analysis on BBWI
Bath & Body Works Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Articles
- Five stocks we like better than Bath & Body Works
- Why Invest in High-Yield Dividend Stocks?
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- The 3 Best Retail Stocks to Shop for in August
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Most active stocks: Dollar volume vs share volume
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.